CAMBRIDGE, Mass., May 16, 2011 – bluebird bio, a leader in the development of innovative gene therapies for severe genetic disorders, today announced the appointment of Jeffrey T. Walsh to the …
TVM Capital Life Science Venture Capital
Investing in Life Science Innovation